PubMed · 1968 · 33 citations · 4 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccinologyVirologyVaccinationVaccine DevelopmentVaccine SafetyVaccine-preventable DiseasesVeterinary VaccinesViral VaccinesCell Culture-based Vaccine ProductionClinical Screening TestsField Evaluation Of VaccinesField Vaccine EvaluationPediatric VaccinationRubella VaccinationVaccine Characterization
Duck embryo cell culture rubella virus vaccines prepared with the HPV-77 (Meyer-Parkman) and the Merck (B-level attenuation) strains of virus were evaluated in a large-scale family study in the open community and in an institution. Of 265 initially seronegative children vaccinated with the HPV-77 virus in duck embryo cell culture, 97% responded serologically with a geometric mean hemagglutination-inhibiting (HI) titer of 1:53.2. There was no apparent clinical illness and no serologic evidence for contact spread to 262 susceptible siblings or to 34 maternal contacts. The performance of the Merck B-level vaccine in duck embryo cell culture in the smaller institutional study was essentially the same as that of the HPV-77 except that the mean HI titer was almost three times as great (1:148.3). Both vaccines proved safe and efficacious in children, and community studies are in progress in larger numbers of persons.
4
Rubella-Virus Hemagglutination-Inhibition Test
George L. Stewart, Paul D. Parkman, Hope E. Hopps et al. · New England Journal of Medicine · 1967 · 420 citations
Paul D. Parkman, Harry M. Meyer, Ruth L. Kirschstein et al. · New England Journal of Medicine · 1966 · 147 citations
Harry M. Meyer, Paul D. Parkman, Theodore C. Panos · New England Journal of Medicine · 1966 · 123 citations